keyword
https://read.qxmd.com/read/38701164/the-safety-of-modified-all-oral-shorter-tuberculosis-regimens-in-armenia
#1
JOURNAL ARTICLE
Hakob Atshemyan, Naira Khachatryan, Anush Khachatryan, Narine Mirzoyan
BACKGROUND: The implementation of modified, all-oral shorter regimens for treatment of rifampicin-resistant tuberculosis has started in Armenia since August 2020 under the conditions of operational research. OBJECTIVE: This study aims to evaluate the safety and effectiveness of shorter regimens. METHODS: We evaluated cumulative incidence rates of serious adverse events, adverse events of grade 3 and greater and events resulting in treatment modifications or suspension for 52 study participants...
May 3, 2024: International Journal of Risk & Safety in Medicine
https://read.qxmd.com/read/38701096/semaglutide-combined-with-empagliflozin-vs-monotherapy-for-non-alcoholic-fatty-liver-disease-in-type-2-diabetes-study-protocol-for-a-randomized-clinical-trial
#2
RANDOMIZED CONTROLLED TRIAL
Yu-Hao Lin, Zhi-Jun Zhang, Jin-Qing Zhong, Zhi-Yi Wang, Yi-Ting Peng, Yan-Mei Lin, Huo-Ping Zhang, Jian-Qing Tian
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is strongly associated with type 2 diabetes mellitus (T2DM). Lifestyle intervention remains a preferred treatment modality for NAFLD. The glucagon-like peptide (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors have been developed as new glucose-lowering drugs, which can improve fatty liver via an insulin-independent glucose-lowering effect. However, studies exploring the efficacy of GLP-1 receptor agonists combined with SGLT-2 inhibitors in patients with NAFLD and T2DM are scanty...
2024: PloS One
https://read.qxmd.com/read/38700323/post-marketing-safety-concerns-with-elagolix-a-disproportionality-analysis-of-the-fda-adverse-event-reporting-system
#3
JOURNAL ARTICLE
En Chang, Yong-Fang Shi, Jin-Feng Liu, Wei Wei
OBJECTIVE: Elagolix is approved for the treatment of moderate-to-severe pain associated with endometriosis. However, the long-term safety of elagolix in a large sample of real-world patients is unknown. METHODS: The U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) reports were collected and analyzed for the first quarter of 2019 through the second quarter of 2023. Disproportionality analyses, including the reporting odds ratio (ROR), the proportional reporting ratio (PRR), the Bayesian confidence propagation neural network (BCPNN), and the multi-item gamma Poisson shrinker (MGPS) algorithms, were employed in data mining to quantify the signals of elagolix-related adverse events (AEs)...
May 3, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38699124/comparison-of-adenosine-deaminase-c-reactive-protein-uric-acid-and-rheumatoid-arthritis-levels-in-patients-with-rheumatoid-arthritis-and-those-without-arthritis-a-review
#4
REVIEW
Priyanka A Makhe, Anjali A Vagga
One of the hallmarks of rheumatoid arthritis (RA) is inflammation of the synovial membrane, and oxidative stress is a mediator of tissue damage. RA is characterized by persistent joint inflammation, which leads to pain, edema, and finally joint destruction. Numerous biochemical markers can cause RA because of their impact on systemic and local inflammation. Numerous biomarkers have been investigated for their potential application in the diagnosis and prognosis of RA. In this review article, we evaluate the role of RA factor or rheumatoid factor (RF), uric acid, C-reactive protein (CRP), and adenosine deaminases (ADAs) as biomarkers in patients with and without arthritis...
April 2024: Curēus
https://read.qxmd.com/read/38699122/the-incidence-of-abnormal-preoperative-testing-among-elective-surgery-patients-in-a-referral-hospital-in-southern-saudi-arabia
#5
JOURNAL ARTICLE
Abdulmajeed Alkhathami, Ahmed Alameer, Osama A Alqarni, Amal T Aljuaid, Elaf S Alrimthi, Saeed Nasser A Alaklabi, Mutasim E Ibrahim
Background Preoperative investigations are important to assess the clinical condition of patients who undergo elective surgical procedures. However, there is still debate about the usefulness of performing preoperative investigations. We aimed to determine the prevalence of routine preoperative investigation abnormalities among elective general surgery patients. Methodology This retrospective hospital-record-based study was conducted at the King Abdullah Hospital in Bisha Province, southern Saudi Arabia. General and clinical data of 968 patients who underwent elective surgical interventions from February 2022 to January 2023 were retrieved and analyzed...
April 2024: Curēus
https://read.qxmd.com/read/38698184/incidence-risk-factors-and-outcomes-of-acute-liver-injury-in-hospitalized-adults-with-acute-kidney-injury-a-large-multicenter-study
#6
JOURNAL ARTICLE
Yuxin Lin, Pingping Li, Yuping Zhang, Qi Gao, Licong Su, Yanqin Li, Ruqi Xu, Yue Cao, Peiyan Gao, Fan Luo, Ruixuan Chen, Xiaodong Zhang, Sheng Nie, Xin Xu
BACKGROUND: Acute kidney injury (AKI) and acute liver injury (ALI) were associated with poor outcomes during hospitalization, respectively. However, the clinical outcome of AKI combined with ALI (AKI-ALI) remains unknown. The current study aimed to describe AKI-ALI's incidences, risk factors, and outcomes. METHODS: The study population included patients aged 18-99 years with enough serum creatinine and liver testing hospitalized at 19 medical centers throughout China between 2000 and 2021...
May 2, 2024: Hepatology International
https://read.qxmd.com/read/38697387/ocular-features-of-ngly1-deficiency-from-a-prospective-longitudinal-cohort
#7
JOURNAL ARTICLE
Christina H Frater, Maura R Z Ruzhnikov, Shannon Beres, Deborah Alcorn, Ann Shue, Rebecca J Levy
BACKGROUND: NGLY1 deficiency is a rare autosomal recessive disorder with core features of global developmental delay, liver enzyme abnormalities, movement disorder, polyneuropathy, and hypo- or alacrima. We characterized the full spectrum and evolution of the ocular phenotype in a prospective natural history of NGLY1 deficiency. METHODS: We collected ophthalmological data on 29 individuals with NGLY1 deficiency in a natural history study. Medical records were reviewed to confirm caregiver-reported symptoms...
April 30, 2024: Journal of AAPOS: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
https://read.qxmd.com/read/38697309/the-fatty-acid-omega-hydroxylase-genes-cyp4-family-in-the-progression-of-metabolic-dysfunction-associated-steatotic-liver-disease-masld-an-rna-sequence-database-analysis-and-review
#8
REVIEW
Charles Leahy, Nicholas Osborne, Leticia Shirota, Paula Rote, Yoon-Kwang Lee, Byoung-Joon Song, Liya Yin, Yanqiao Zhang, Victor Garcia, James P Hardwick
Fatty acid omega hydroxylase P450s consist of enzymes that hydroxylate various chain-length saturated and unsaturated fatty acids (FAs) and bioactive eicosanoid lipids. The human cytochrome P450 gene 4 family (CYP4) consists of 12 members that are associated with several human diseases. However, their role in the progression of metabolic dysfunction-associated fatty liver disease (MASLD) remains largely unknown. It has long been thought that the induction of CYP4 family P450 during fasting and starvation prevents FA-related lipotoxicity through FA metabolism to dicarboxylic acids that are chain-shortened in peroxisomes and then transported to the mitochondria for complete oxidation...
April 30, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38697306/role-of-resmetirom-a-liver-directed-thyroid-hormone-receptor-beta-selective-agonist-in-managing-non-alcoholic-steatohepatitis-a-systematic-review-and-meta-analysis
#9
JOURNAL ARTICLE
Deep Dutta, A B M Kamrul-Hasan, Ershad Mondal, Lakshmi Nagendra, Ameya Joshi, Saptarshi Bhattacharya
BACKGROUND: Resmetirom, a liver-directed, thyroid hormone receptor beta-selective agonist, has recently been approved to treat non-alcoholic steatohepatitis (NASH). This meta-analysis aimed to summarize the efficiency and safety of resmetirom in treating NASH. METHODS: Electronic databases were searched for randomized controlled trials (RCTs) of resmetirom vs. placebo in patients with NASH. The primary outcomes were the changes from baseline in hepatic fat content, liver histology, including NASH resolution, and non-invasive markers of hepatic fibrosis...
April 30, 2024: Endocrine Practice
https://read.qxmd.com/read/38697280/h-ras-targeted-genetic-therapy-remarkably-surpassed-docetaxel-treatment-in-inhibiting-chemically-induced-hepatic-tumors-in-rats
#10
JOURNAL ARTICLE
Alankar Mukherjee, Ramkrishna Sen, Ashique Al Hoque, Tapan Kumar Giri, Biswajit Mukherjee
AIMS: Hepatocellular carcinoma (HCC) is still a leading cause of cancer-related death worldwide. But its chemotherapeutic options are far from expectation. We here compared H-ras targeted genetic therapy to a commercial docetaxel formulation (DXT) in inhibiting HCC in rats. MAIN METHODS: After the physicochemical characterization of phosphorothioate-antisense oligomer (PS-ASO) against H-ras mutated gene, the PS-ASO-mediated in vitro hemolysis, in vivo hepatic uptake, its pharmacokinetic profile, tissue distribution in some highly perfused organs, its effect in normal rats, antineoplastic efficacy in carcinogen-induced HCC in rats were evaluated and compared against DXT treatment...
April 30, 2024: Life Sciences
https://read.qxmd.com/read/38696681/protocatechuic-acid-modulates-hepatic-oxidative-stress-and-inflammation-linked-to-dmn-exposure-in-rat
#11
JOURNAL ARTICLE
Folake Asejeje, Sylvia Etim, Gbolahan Asejeje, Benneth Chukwudi Iwuoh, Sanmi Ibukunoluwa Akintade, Isaac Adedara, Ebenezer Olatunde Farombi
Dimethyl nitrosamine (DMN), a potent hepatotoxin, exerts carcinogenic effects and induces hepatic necrosis in experimental animals via CYP2E1 metabolic activation, and generation of reactive oxygen species (ROS). Protocatechuic acid (PCA), a plant-based simple phenolic compound and potent antioxidant, has been shown to affect the development of neoplasia in the rat liver and inhibit the initiation or progression phases of most cancers. In this study, the modulatory effects of PCA on DMN-induced hepatotoxicity, oxidative stress, inflammation, and selected phase I xenobiotic metabolizing enzymes were investigated in male Wistar rats...
December 31, 2023: Nigerian Journal of Physiological Sciences: Official Publication of the Physiological Society of Nigeria
https://read.qxmd.com/read/38696369/liver-specific-mitochondrial-amidoxime-reducing-component-1-mtarc1-knockdown-protects-the-liver-from-diet-induced-mash-in-multiple-mouse-models
#12
JOURNAL ARTICLE
Yuanjun Guo, Zhengyu Gao, Edward L LaGory, Lewis Wilson Kristin, Jamila Gupte, Yan Gong, Matthew J Rardin, Tongyu Liu, Thong T Nguyen, Jason Long, Yi-Hsiang Hsu, Justin K Murray, Julie Lade, Simon Jackson, Jun Zhang
BACKGROUND: Human genetic studies have identified several mitochondrial amidoxime-reducing component 1 (MTARC1) variants as protective against metabolic dysfunction-associated steatotic liver disease. The MTARC1 variants are associated with decreased plasma lipids and liver enzymes and reduced liver-related mortality. However, the role of mARC1 in fatty liver disease is still unclear. METHODS: Given that mARC1 is mainly expressed in hepatocytes, we developed an N-acetylgalactosamine-conjugated mouse Mtarc1 siRNA, applying it in multiple in vivo models to investigate the role of mARC1 using multiomic techniques...
May 1, 2024: Hepatology Communications
https://read.qxmd.com/read/38695547/improvement-of-%C3%AE-cell-function-after-switching-from-dpp-4-inhibitors-to-oral-semaglutide-switch-sema2-post-hoc-analysis
#13
JOURNAL ARTICLE
Hiroshi Nomoto, Sho Furusawa, Hiroki Yokoyama, Yuka Suzuki, Rimi Izumihara, Yuki Oe, Kiyohiko Takahashi, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi, Yoshio Kurihara, Akinobu Nakamura, Tatsuya Atsumi
CONTEXT: Whether continuation of dipeptidyl peptidase-4 inhibitors (DPP-4is) or switching to oral semaglutide is more beneficial for β-cell function is unclear. OBJECTIVE: To assess the efficacy of switching from DPP-4is to oral semaglutide for β-cell function compared with DPP-4i continuation. METHODS: Post hoc analysis of SWITCH-SEMA 2, a multicenter prospective randomized controlled trial on the switch to oral semaglutide vs DPP-4i continuation without dose adjustment for 24 weeks in subjects with type 2 diabetes treated with DPP-4is, was conducted...
May 2, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38695249/effects-of-swimming-activity-and-feed-restriction-on-antioxidant-and-digestive-enzymes-in-juvenile-rainbow-trout-implications-for-nutritional-and-exercise-strategies-in-aquaculture
#14
JOURNAL ARTICLE
Gökhan Tunçelli, Onur Ertik, Bertan Boran Bayrak, Devrim Memiş, Refiye Yanardag
BACKGROUND: In this study, we investigated the effects of swimming activity and feed restriction on digestion and antioxidant enzyme activities in juvenile rainbow trout (average body weight of 26.54 ± 0.36 g). METHODS: The stomach, liver and kidney tissues were obtained from four distinct groups: the static water group (fish were kept in static water and fed to satiation), the feeding restricted group (fish were kept in static water with a 25% feed restriction), the swimming exercised group (fish were forced to swimming at a flow rate of 1 Body Length per second (BL/s)) and the swimming exercised-feed restricted group (subjected to swimming exercise at a 1 BL/s flow rate along with a 25% feed restriction)...
May 2024: Veterinary Medicine and Science
https://read.qxmd.com/read/38694481/liver-transcriptome-and-physiological-analyses-preliminarily-revealed-the-adaptation-mechanisms-of-amur-grayling-thymallus-arcticus-grubei-dybowski-1869-fry-for-dietary-lipid-nutrition
#15
JOURNAL ARTICLE
Ze Fan, Kai Ma, Yan Wang, Liansheng Wang, Yongquan Zhang, Chenhui Li, Jiaxin Li, Di Wu, Jinnan Li, Zhengwei Li
The Amur grayling ( Thymallus arcticus grubei Dybowski, 1869), a species of potentially economic and research value, is renowned for its tender meat, exquisite flavor, and high nutritional contents. This study was conducted to investigate the physiological adaptation mechanisms to dietary lipids in Amur grayling fry (with average initial weight 4.64±0.03 g). This study involved a 56-day feeding trial with diets containing varying lipid levels (9.07%, 12.17%, 15.26%, 18.09%, 21.16%, and 24.07%, designated as GL1 through GL6, respectively) to explore the impact of dietary lipids on growth performance, intestinal digestion, liver antioxidative function, and transcriptomic profiles...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38694424/comprehensive-surgical-audit-of-live-related-donor-nephrectomy-procedural-parameters-demographics-health-assessments-complications-and-postoperative-outcomes
#16
JOURNAL ARTICLE
Khalid Mahmood, Ahsan Ahmad, Rohit Upadhyay, Takallum Khatoon, Zaid Imbisat, Ankur Akela
BACKGROUND AND OBJECTIVES: End-stage renal disease (ESRD) rates are on the rise globally, including in India. However, the affordability of dialysis treatment remains a significant challenge for many, with costs varying across different regions. Although cost-effective, kidney transplantation faces challenges like a surgeon shortage, lack of infrastructure, and lack of logistic support. The study examines Indian laparoscopic nephrectomy outcomes and their benefits for donor recovery. It covers kidney donor procedural details, demographics, preoperative health evaluations, complications, and one-month follow-up...
March 2024: Curēus
https://read.qxmd.com/read/38694306/the-therapeutic-effect-of-alcoholic-extract-of-fumaria-parviflora-on-high-fat-diet-induced-nonalcoholic-fatty-liver-in-rats-an-animal-experiment
#17
JOURNAL ARTICLE
Shayan Eghdami, Fatemeh Afrashteh, Asie Shojaii, Maryam Abolhasani, Manijeh Motevalian
BACKGROUND AND PURPOSE: Nonalcoholic fatty liver disease (NAFLD) is a growing problem with a significant burden. Lifestyle modification is the recommended treatment, but researchers are exploring other options. This study focused on the effects of Fumaria parviflora (FP) extracts on NAFLD induced by a high-fat diet in rats. EXPERIMENTAL APPROACH: Thirty-five 10-week-old male Wister-Albino rats were divided into seven groups: normal diet control, high fat diet control, high fat diet with oral normal saline gavage, high fat diet with oral Atorvastatin gavage, and three groups receiving high fat diet with FP extract in 200 mg/kg, 400 mg/kg, and 700 mg/kg...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38692892/the-regulatory-mechanism-of-smilax-china-l-saponins-against-nonalcoholic-fatty-liver-is-revealed-by-metabolomics-and-transcriptomics
#18
JOURNAL ARTICLE
Cuiyu Li, Bin Fang, Yuanyuan Wei, Rou Mo, Xing Lin, Quanfang Huang
This study was to investigate the effects of Smilax China L. saponins (SCS) on non-alcoholic fatty liver disease (NAFLD). Rats were fed a high-fat diet (HFD) for 8 weeks to induce NAFLD, followed by SCS treatment for 8 weeks. The effect of SCS on liver injury was observed by H&E staining and the regulative mechanism of SCS on lipid formation was exposed by detecting Oil red O, insulin resistance (IR), and fatty acids synthesis (FAS). Furthermore, transcriptomics and metabolomics were performed to analyze the potential targets...
2024: Journal of Oleo Science
https://read.qxmd.com/read/38692452/liensinine-alleviates-sepsis-induced-acute-liver-injury-by-inhibiting-the-nf-%C3%AE%C2%BAb-and-mapk-pathways-in-an-nrf2-dependent-manner
#19
JOURNAL ARTICLE
Xiao Zhang, Silong Yuan, Hui Fan, Wei Zhang, Honggang Zhang
Sepsis remains a serious public health issue that needs to be addressed globally. Severe liver injury caused by sepsis increases the risk of death in patients with sepsis. Liensinine (Lie) is one of the primary active components in Plumula nelumbinis and has anti-inflammatory and antioxidant effects. Nevertheless, the effects of Lie on septic liver injury are unclear. This research investigated the protective effect of Lie (10, 20 and 40 mg/kg) on liver damage via intraperitoneal administration of LPS (10 mg/kg) to C57BL/6 mice...
April 29, 2024: Chemico-biological Interactions
https://read.qxmd.com/read/38692354/multi-omics-analysis-reveals-leucine-deprivation-promotes-bile-acid-synthesis-by-upregulating-hepatic-cyp7a1-and-intestinal-turicibacter-sanguinis-in-mice
#20
JOURNAL ARTICLE
Yao-Rong Niu, Hao-Nan Yu, Zhen-Hong Yan, Xiang-Hua Yan
BACKGROUND: Leucine, a branched-chain amino acid (BCAA), participates in the regulation of lipid metabolism and the composition of the intestinal microbiota. However, the related mechanism remains unclear. OBJECTIVES: Here, we aimed to reveal the potential mechanisms by which the hepatic CYP7A1 (a rate-limiting enzyme for bile acid [BA] synthesis) and gut microbiota co-regulated BA synthesis under leucine deprivation. METHODS: To this aim, 8-week-old C57BL/6J mice were fed with either regular diets or leucine-free diets for 1 week...
April 29, 2024: Journal of Nutrition
keyword
keyword
63830
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.